Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide
Sign Up to like & getrecommendations! Published in 2019 at "Endocrine"
DOI: 10.1007/s12020-019-01996-9
Abstract: To evaluate the impact of temozolomide (TMZ) introduction on the survival of patients with pituitary carcinoma (PC) compared to aggressive pituitary adenoma (APA). Retrospective analysis of the Surveillance Epidemiology and End-Results database (SEER), including patients… read more here.
Keywords: introduction; harboring pituitary; cause mortality; patients harboring ... See more keywords
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2017.02.001
Abstract: Introduction: Little is known about the prevalence, prognosis, and response to treatment of advanced NSCLC harboring multiple genomic alterations. Methods: The French Biomarkers France database, which includes 17,664 patients, was used. The prevalence of multiple… read more here.
Keywords: versus months; multiple molecular; harboring multiple; patients harboring ... See more keywords
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
Sign Up to like & getrecommendations! Published in 2020 at "Blood Cancer Journal"
DOI: 10.1038/s41408-020-0307-4
Abstract: Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents Roberto Mina , Nisha S. Joseph, Francesca Gay , Efstathios Kastritis , Maria Teresa Petrucci, Jonathan L. Kaufman ,… read more here.
Keywords: clinical features; myeloma patients; patients harboring; survival multiple ... See more keywords
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14143472
Abstract: Simple Summary Non-small cell lung cancer (NSCLC) patients harboring BRAF non-V600 alterations constitute a heterogeneous and poorly studied population orphan of targeted therapies. We conducted a systematic review to detect all BRAF alterations of defined… read more here.
Keywords: cancer; braf alterations; nsclc patients; class ... See more keywords